Medicine and Dentistry
Intestinal Failure
100%
ANCA Associated Vasculitis
100%
Prevalence
70%
Home Parenteral Nutrition
66%
Hazard Ratio
58%
Cardiovascular System
49%
Cross Sectional Study
36%
Sarcopenia
33%
Cardiovascular Disease
33%
Peripherally Inserted Central Catheter
33%
Catheter Infection
33%
ECG Abnormality
33%
Nephrotic Syndrome
33%
Endothelial Function
33%
Cardiovascular Mortality
27%
Thrombin
25%
Fibrinolysis
25%
Thrombocyte Function
25%
Implantable Automatic Defibrillator
18%
Infection
16%
Antithrombotic
16%
Endothelial Cell
16%
Heart Ventricle Arrhythmia
16%
Venous Thromboembolism
12%
Proportional Hazards Model
12%
Electrocardiogram
11%
Heart Arrest
10%
Atrial Fibrillation
10%
Heart Failure
9%
Brain Ischemia
9%
Survival Analysis
8%
Phlebitis
8%
Parenteral Nutrition
8%
Student T Test
8%
Medical Record
8%
Anticoagulant
8%
Thrombosis
8%
Blood Stasis
8%
Anticoagulant Therapy
8%
Glomerular Filtration Rate
8%
Cell Marker
8%
Cell Function
8%
Thrombophilia
8%
Prothrombin
8%
Cancer
8%
Serum Albumin
8%
Thrombocyte Aggregation
8%
Von Willebrand Factor
8%
Ischemic Heart Disease
6%
Alcohol Consumption
6%
Keyphrases
Cardiovascular Events
47%
Hazard Ratio
44%
Hemodialysis
42%
Multicenter Cohort Study
38%
Cardiovascular Risk
38%
Maintenance Hemodialysis
38%
Long-term Cardiovascular Outcomes
33%
Outcome Trends
33%
ANCA-associated Vasculitis
33%
Cardiovascular Disease Risk
33%
Intestinal Insufficiency
33%
Renin-angiotensin-aldosterone System
33%
Hyperkalemia
33%
Feasibility Trial
33%
Albuminuria
33%
Chronic Kidney Disease
33%
Patiromer
33%
Cardiovascular Mortality
33%
Secretin
33%
Non-associated
33%
N-3 Polyunsaturated Fatty Acids
33%
Coagulation Function
33%
All-cause Mortality
28%
Confidence Interval
23%
Catheter-related Bloodstream Infection (CRBSI)
16%
Potassium Binders
16%
Low Risk
14%
Major Adverse Cardiovascular Events
12%
Cardiovascular Outcomes
12%
Potassium
11%
Trial Design
11%
High Risk
9%
Peripheral Arterial Disease
9%
Docosahexaenoic Acid
9%
Eicosapentaenoic Acid
9%
Cardiac Arrest
8%
Ventricular Arrhythmia
8%
Cardioverter-defibrillator Implantation
8%
Microscopic Polyangiitis
6%
Retrospective Longitudinal Study
5%
Albumin-to-creatinine Ratio
5%
Losartan
5%
Clinical Decision-making
5%
Laboratory Results
5%
Spironolactone
5%
Randomized Trial
5%
Chronic Kidney Disease Patients
5%
Estimated Glomerular Filtration Rate
5%
Screening Effort
5%
Major Selection
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
33%
Sarcopenia
33%
Intestinal Failure
33%
Albuminuria
33%
Hyperkalemia
33%
Patiromer
33%
Aldosterone
33%
Renin
33%
Angiotensin
33%
Chronic Kidney Failure
33%
Secretoneurin
33%
Omega-3 Fatty Acid
33%
Polyunsaturated Fatty Acid
33%
Hemodialysis
33%
All Cause Mortality
33%
Nephrotic Syndrome
33%
Cross Sectional Study
33%
Isotopes of Potassium
27%
Anticoagulant Agent
19%
Peripheral Occlusive Artery Disease
16%
Docosahexaenoic Acid
16%
Icosapentaenoic Acid
16%
Thrombin
14%
Vitamin D
13%
Cross-Sectional Study
11%
Phlebitis
8%
Cardiovascular Risk
8%
Cohort Study
8%
Glucocorticoid
6%
Malabsorption
6%
Trace Element
6%
Hypovitaminosis D
6%
Vitamin D Deficiency
6%
Proton Pump Inhibitor
6%
Opiate
6%
Losartan
5%
Creatinine
5%
Spironolactone
5%
